Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers
NCT00171262
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Dyslipidemia
Interventions
DRUG:
Fluvastatin
Sponsor
Novartis